TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $52,249,000 | +2.3% | 53,350,000 | -1.8% | 0.06% | -11.8% |
| Q1 2020 | $51,051,000 | -1.6% | 54,310,000 | -0.3% | 0.07% | +44.7% |
| Q4 2019 | $51,892,000 | +4.2% | 54,480,000 | 0.0% | 0.05% | -4.1% |
| Q3 2019 | $49,782,000 | -0.2% | 54,480,000 | 0.0% | 0.05% | +6.5% |
| Q2 2019 | $49,879,000 | -1.5% | 54,480,000 | 0.0% | 0.05% | -8.0% |
| Q1 2019 | $50,624,000 | -0.5% | 54,480,000 | -3.5% | 0.05% | -10.7% |
| Q4 2018 | $50,869,000 | -4.0% | 56,480,000 | 0.0% | 0.06% | +16.7% |
| Q3 2018 | $53,008,000 | +1.4% | 56,480,000 | 0.0% | 0.05% | -5.9% |
| Q2 2018 | $52,274,000 | +42.7% | 56,480,000 | +36.2% | 0.05% | +45.7% |
| Q1 2018 | $36,624,000 | +0.0% | 41,480,000 | 0.0% | 0.04% | +20.7% |
| Q4 2017 | $36,606,000 | -2.4% | 41,480,000 | 0.0% | 0.03% | -12.1% |
| Q3 2017 | $37,506,000 | -16.1% | 41,480,000 | 0.0% | 0.03% | -23.3% |
| Q2 2017 | $44,695,000 | +0.6% | 41,480,000 | 0.0% | 0.04% | -2.3% |
| Q1 2017 | $44,432,000 | -3.3% | 41,480,000 | 0.0% | 0.04% | +7.3% |
| Q4 2016 | $45,951,000 | -11.6% | 41,480,000 | -4.5% | 0.04% | -19.6% |
| Q3 2016 | $51,963,000 | -5.5% | 43,455,000 | 0.0% | 0.05% | -13.6% |
| Q2 2016 | $54,971,000 | -1.8% | 43,455,000 | +1.2% | 0.06% | -7.8% |
| Q1 2016 | $55,955,000 | -45.8% | 42,955,000 | -34.9% | 0.06% | -45.3% |
| Q4 2015 | $103,164,000 | +21.2% | 66,025,000 | +4.9% | 0.12% | +15.8% |
| Q3 2015 | $85,103,000 | +3700.9% | 62,955,000 | +3822.4% | 0.10% | +4950.0% |
| Q2 2015 | $2,239,000 | +63.3% | 1,605,000 | +60.5% | 0.00% | 0.0% |
| Q4 2014 | $1,371,000 | +6.4% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,289,000 | +0.5% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,283,000 | +0.7% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,274,000 | +19.4% | 1,000,000 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $1,067,000 | +2.4% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,042,000 | -1.0% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $1,053,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 83,413,000 | $130,650,000 | 6.13% |
| AEGON USA Investment Management, LLC | 6,000,000 | $9,368,000 | 2.35% |
| MACKAY SHIELDS LLC | 24,370,000 | $38,152,000 | 2.07% |
| INCOME RESEARCH & MANAGEMENT | 4,374,000 | $6,829,000 | 1.11% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 20,000 | $20,347,000 | 0.99% |
| SHENKMAN CAPITAL MANAGEMENT INC | 5,269,000 | $8,264,000 | 0.82% |
| Mitsubishi UFJ Securities Holdings Co., Ltd. | 325,000 | $511,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,299,000 | $14,598,000 | 0.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 14,543,000 | $23,021,000 | 0.35% |
| CSS LLC/IL | 3,750,000 | $5,893,000 | 0.35% |